Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
China · Delayed Price · Currency is CNY 7.05
-0.16 (-2.22%)
May 21, 2026, 3:04 PM CST
SHE:300636 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 71.09 | 73.09 | 106.58 | 105.98 | 100.67 | 81.12 |
Depreciation & Amortization | 131 | 131 | 114.77 | 69.39 | 66.88 | 51.58 |
Other Amortization | 0.68 | 0.68 | - | - | - | - |
Loss (Gain) From Sale of Assets | 0.77 | 0.77 | 1.17 | 1.32 | 0.18 | 1.01 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | -0.04 |
Loss (Gain) From Sale of Investments | 0.9 | 0.9 | -0.62 | -0.57 | 1.21 | -0.28 |
Provision & Write-off of Bad Debts | 1.22 | 1.22 | 1.27 | -0.11 | 1.48 | 2.11 |
Other Operating Activities | 63.65 | 74.85 | 39.78 | 22.96 | 15 | 10.48 |
Change in Accounts Receivable | -37.2 | -37.2 | -12.49 | 22.41 | -11.52 | -61.27 |
Change in Inventory | -20.13 | -20.13 | -55.66 | -45.2 | -131.24 | -42.8 |
Change in Accounts Payable | 31.45 | 31.45 | 100.72 | -23.01 | 133.01 | 85.34 |
Change in Other Net Operating Assets | -56.83 | -56.83 | -16.3 | 4.33 | 14.85 | -3.12 |
Operating Cash Flow | 188.87 | 202.07 | 285.19 | 163.75 | 196 | 131.34 |
Operating Cash Flow Growth | -35.12% | -29.14% | 74.16% | -16.45% | 49.23% | 64.04% |
Capital Expenditures | -282.43 | -291.24 | -136.49 | -214.65 | -311.49 | -424.67 |
Sale of Property, Plant & Equipment | 0.45 | 0.39 | 0.49 | 0.23 | 1.12 | 0.44 |
Investment in Securities | 114.69 | 273.57 | -370.33 | -493.96 | -30 | -20 |
Other Investing Activities | 0.37 | 0.37 | 0.68 | 2.18 | -1.61 | 0.02 |
Investing Cash Flow | -166.92 | -16.91 | -505.65 | -706.21 | -341.99 | -444.21 |
Long-Term Debt Issued | - | 459.89 | 870.49 | 924.7 | 391.74 | 427.46 |
Long-Term Debt Repaid | - | -526.73 | -937.36 | -770.72 | -285.68 | -211.16 |
Net Debt Issued (Repaid) | -173.52 | -66.84 | -66.87 | 153.98 | 106.06 | 216.3 |
Issuance of Common Stock | - | - | - | 789.82 | 41.42 | - |
Repurchase of Common Stock | -12.34 | -12.34 | -12.98 | -0.43 | - | - |
Common Dividends Paid | -27.86 | -28.78 | -29.12 | -26.91 | -32.11 | -21.8 |
Other Financing Activities | 10.09 | 10 | -2 | 38.8 | -46.8 | -6.82 |
Financing Cash Flow | -203.62 | -97.96 | -110.97 | 955.26 | 68.57 | 187.68 |
Foreign Exchange Rate Adjustments | -4.29 | 0.23 | 4.05 | 1.82 | 1.13 | -0.74 |
Net Cash Flow | -185.97 | 87.43 | -327.39 | 414.62 | -76.29 | -125.93 |
Free Cash Flow | -93.56 | -89.17 | 148.7 | -50.9 | -115.5 | -293.33 |
Free Cash Flow Margin | -11.33% | -10.76% | 19.59% | -7.05% | -16.04% | -49.54% |
Free Cash Flow Per Share | -0.22 | -0.21 | 0.35 | -0.13 | -0.33 | -0.87 |
Cash Income Tax Paid | - | -46.55 | -27.75 | -41.2 | -84.82 | -59.22 |
Levered Free Cash Flow | -598.44 | -113.98 | 0.53 | -201.9 | -197.59 | -293.72 |
Unlevered Free Cash Flow | -591.04 | -106.16 | 11.87 | -195.72 | -192.78 | -290.16 |
Change in Working Capital | -80.44 | -80.44 | 22.24 | -35.23 | 10.57 | -14.64 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.